Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: READE SMITH who wrote (639)	11/14/1997 7:10:00 PM
From: Mark Bartlett	Respond to of 14101

Reade, << If WF-10 is ever approved for use in North America we're looking at $75-$100 stock.>> Why so low ? <G> ..... if we really get lucky, and they both get approved, 100 bucks is certainly very possible .... but, let's wait until we have some news before we get "irrationally exhuberant" <g> There is always a chance neither would get approved - but that is highly unlikely at this point. BTW - there was an article in the FP today, indicating the gurus of the cocktail approach had to finally admit this approach was not going to work .... the virus is just too smart. Looks like there will be lots of room for WF10 .... I hope so for the people that that need it. Apparently the United Kingdom has already gotten back to DMX with some additional questions re: Pennsaid - and the requested info has been forwarded. Seems they work much faster than the Canadian government ... they have also been forwarded additional info - but they (the canucks) have been in the game longer too. Let's hope they can submit to the FDA soon for Pennsaid - that would certainly be positive. Be nice to hear about WF10 moving on to phase 3 AIDS trials and/or cancer trials too. Good things come to those who wait ... I (we) hope! All the Best, MB